Cargando…

DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma Cells

Tumor cells might resist therapy with ionizing radiation (IR) by non-homologous end-joining (NHEJ) of IR-induced double-strand breaks. One of the key players in NHEJ is DNA-dependent protein kinase (DNA-PK). The catalytic subunit of DNA-PK, i.e. DNA-PKcs, can be inhibited with the small-molecule inh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dolman, M. Emmy M., van der Ploeg, Ida, Koster, Jan, Bate-Eya, Laurel Tabe, Versteeg, Rogier, Caron, Huib N., Molenaar, Jan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696738/ https://www.ncbi.nlm.nih.gov/pubmed/26716839 http://dx.doi.org/10.1371/journal.pone.0145744

Ejemplares similares

High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition
por: Bate-Eya, Laurel T., et al.
Publicado: (2016)

Identification of BIRC6 as a novel intervention target for neuroblastoma therapy
por: Lamers, Fieke, et al.
Publicado: (2012)

MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma
por: Eleveld, Thomas F., et al.
Publicado: (2023)

Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastoma
por: van den Boogaard, Marlinde L., et al.
Publicado: (2021)

A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients
por: Fardin, Paolo, et al.
Publicado: (2010)

Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel
por: van Wezel, Esther M., et al.
Publicado: (2019)

Prevalence of congenital heart defects in neuroblastoma patients: a cohort study and systematic review of literature
por: van Engelen, Klaartje, et al.
Publicado: (2008)

Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma
por: Keller, Kaylee M., et al.
Publicado: (2022)

Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism
por: Mandriota, Stefano J., et al.
Publicado: (2015)

DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
por: Olsen, Thale Kristin, et al.
Publicado: (2022)

Neuroblastoma and DIPG Organoid Coculture System for Personalized Assessment of Novel Anticancer Immunotherapies
por: M. Kholosy, Waleed, et al.
Publicado: (2021)

Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
por: George, Sally L, et al.
Publicado: (2020)

Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics
por: van Gerven, Michael R., et al.
Publicado: (2022)

TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
por: Decaesteker, Bieke, et al.
Publicado: (2018)

Anti-GD2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells
por: Gholizadeh, Shima, et al.
Publicado: (2018)

The role of (131)I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma
por: Schoot, Reineke A., et al.
Publicado: (2013)

Modulation of Neuroblastoma Disease Pathogenesis By An Extensive Network of Epigenetically Regulated MicroRNAs
por: Das, Sudipto, et al.
Publicado: (2012)

Fenretinide induces mitochondrial ROS and inhibits the mitochondrial respiratory chain in neuroblastoma
por: Cuperus, Roos, et al.
Publicado: (2009)

p53-Mediated Radiosensitization of (177)Lu-DOTATATE in Neuroblastoma Tumor Spheroids
por: Lundsten, Sara, et al.
Publicado: (2021)

Intratumour Diversity of Chromosome Copy Numbers in Neuroblastoma Mediated by On-Going Chromosome Loss from a Polyploid State
por: Lundberg, Gisela, et al.
Publicado: (2013)

Two opposing gene expression patterns within ATRX aberrant neuroblastoma
por: van Gerven, Michael R., et al.
Publicado: (2023)

A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma
por: van Groningen, Tim, et al.
Publicado: (2019)

Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma
por: Spel, Lotte, et al.
Publicado: (2015)

Joint Binding of OTX2 and MYC in Promotor Regions Is Associated with High Gene Expression in Medulloblastoma
por: Bunt, Jens, et al.
Publicado: (2011)

Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients
por: Cangelosi, Davide, et al.
Publicado: (2013)

Toxicity of upfront (131)I-metaiodobenzylguanidine ((131)I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis
por: Bleeker, Gitta, et al.
Publicado: (2013)

Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome
por: Cornero, Andrea, et al.
Publicado: (2012)

Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patients
por: Cangelosi, Davide, et al.
Publicado: (2014)

MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis
por: Bleeker, Gitta, et al.
Publicado: (2014)

Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth
por: Ménard, Marie, et al.
Publicado: (2018)

CD44 Expression in Intestinal Epithelium and Colorectal Cancer Is Independent of p53 Status
por: Zeilstra, Jurrit, et al.
Publicado: (2013)

Calreticulin Expression Controls Cellular Redox, Stemness, and Radiosensitivity to Function as a Novel Adjuvant for Radiotherapy in Neuroblastoma
por: Chen, Chih-Jung, et al.
Publicado: (2023)

Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells
por: Vella, Serena, et al.
Publicado: (2016)

Relationship between thyroid tumor radiosensitivity and nuclear localization of DNA-dependent protein kinase catalytic subunit
por: Ihara, Makoto, et al.
Publicado: (2020)

123I‐MIBG scintigraphy and 18F‐FDG‐PET imaging for diagnosing neuroblastoma
por: Bleeker, Gitta, et al.
Publicado: (2015)

Discovery and visualization of miRNA–mRNA functional modules within integrated data using bicluster analysis
por: Bryan, Kenneth, et al.
Publicado: (2014)

Targeting anaplastic lymphoma kinase in neuroblastoma
por: Umapathy, Ganesh, et al.
Publicado: (2019)

Metabolic protein kinase signalling in neuroblastoma
por: Smiles, William J., et al.
Publicado: (2023)

Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells
Publicado: (1995)

Radiosensitization by Kinase Inhibition Revealed by Phosphoproteomic Analysis of Pancreatic Cancer Cells
por: Wiechmann, Svenja, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1q3hhhc0ij478pkmdi823qhqve